California Carcinoid and Neuroendocrine Tumor Conference Scheduled for January
Carcinoid and neuroendocrine tumor patients and their families are invited to attend the 2012 NET Patient Half Day Conference on Sunday, January 22 in San Francisco, California. The latest developments in NET cancers, including clinical trials, …READ MORE
Carcinoid Cancer Foundation Announces New Video Series
In recognition and support of Worldwide NET Cancer Awareness Day, the Carcinoid Cancer Foundation is pleased to announce a new video series that will begin in 2012. This series, made possible by the generosity of Kim, Heather and Lauren Simpson and other…READ MORE
Racing for a Cause: Carcinoid Car Selected as Finalist in Sponsafier Competition!
Fantastic news! The top ten finalists have been announced and the CARCINOID CAR is a Finalist in the Sponsafier competition! There are 15 days left to vote for the next Sponsafier Champion. We need your help – please vote every day from today, October 5,…READ MORE
Pancreatic Neuroendocrine Tumors: A Rare Cancer
From your next door neighbor to Steve Jobs, co-founder of Apple who just announced that he is stepping down as CEO of the company, pancreatic neuroendocrine tumors (pNETs) affect less than 1 person in 100,000 in the United States. This rare cancer is often…READ MORE
9 Conferences for the Carcinoid and Neuroendocrine Tumor Community
If you are a carcinoid or NET cancer survivor, caregiver, family member or medical professional you can learn about what’s happening now and what’s new in carcinoid/NETs treatments, clinical trials, research, and more from specialists…READ MORE
Happy 4th of July from The Carcinoid Cancer Foundation
The Carcinoid Cancer Foundation wishes all carcinoid and neuroendocrine tumor survivors, family, caregivers, friends, colleagues, and the medical community who celebrate Independence Day a happy and safe holiday.
… READ MORE
Carcinoid Cancer Foundation’s May 2011 Symposium Now Online
The Carcinoid Cancer Foundation is pleased to share with you videos from its carcinoid/NET symposium, “Neuroendocrine Tumor Management: The Era of Personalized Medicine,” held on May 1, 2011 at Mt. Sinai Medical Center in New York City.
Following …READ MORE
Now Recruiting: Carcinoid Syndrome Patients to Participate in Clinical Trial
Ipsen is recruiting patients with a history of carcinoid syndrome to participate in a clinical study to evaluate the effect of Somatuline® Depot (Lanreotide Autogel), a somatostatin analog (SSTa) similar to octreotide, on the control of symptoms …READ MORE
Up-to-the-Minute: News for the Carcinoid and Neuroendocrine Tumor Community
The first device that simultaneously performs PET and MRI scans, a new alpha-emitter-based therapy for NET cancer patients with progressive therapy-resistant tumors, the first–ever randomized virtual clinical trial, over 100 abstracts on carcinoid…READ MORE
Carcinoid Cancer Foundation to Speak on Behalf of NET Cancer Patients at April 12, 2011 FDA Oncologic Drugs Advisory Committee Meeting
Grace Goldstein, Chief Operating Officer of the Carcinoid Cancer Foundation, will speak at the Open Public Hearing segment during the U.S. Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee Meeting on April 12, 2011 in Silver …READ MORE